EVLO (Evelo Biosciences) Total Operating Expense: $74.34 Mil (TTM As of Sep. 2023)


What is Evelo Biosciences Total Operating Expense?

Evelo Biosciences EVLO -99.00% Total Operating Expense is $74.34 Mil as of Sep. 2023.

Evelo Biosciences's Total Operating Expense for the three months ended in Sep. 2023 was $10.39 Mil. Evelo Biosciences's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was $74.34 Mil.

Evelo Biosciences Total Operating Expense Related Terms

Evelo Biosciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences Total Operating Expense Chart

Evelo Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Operating Expense
Get a 7-Day Free Trial 58.10 86.36 91.89 115.40 108.47

Evelo Biosciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.05 21.09 24.90 17.96 10.39

Evelo Biosciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $74.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $74.34 Mil mean?
Evelo Biosciences (EVLO) has a Total Operating Expense of $74.34 Mil as of Sep. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Evelo Biosciences and its competitors.
Is Evelo Biosciences' Total Operating Expense too high?
Evelo Biosciences' current Total Operating Expense is $74.34 Mil.
How does Evelo Biosciences' Total Operating Expense compare to IMNN and EDSA?
Evelo Biosciences' Total Operating Expense of $74.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Evelo Biosciences and its competitors. Evelo Biosciences's current Total Operating Expense is $74.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Total Operating Expense of $74.34 Mil. The current Total Operating Expense is $74.34 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Total Operating Expense is $74.34 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.